Your browser of choice has not been tested for use with Barchart.com. If you have issues, please download one of the browsers listed here.
Stocks | Futures | Watchlist | More
or

Abiomed Inc (ABMD)

Abiomed Inc (ABMD)

[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Profile for [[ item.sessionDateDisplayLong ]]

Company Info

Abiomed Inc 22 CHERRY HILL DR DANVERS MA 01923 USA

P: 978-646-1400 F: 978-777-8411

Description:

Abiomed, Inc. is a provider of mechanical circulatory support devices and offers a continuum of care to heart failure patients. The Company develops, manufactures and markets proprietary products that are designed to enable the heart to rest, heal and recover by improving blood flow and/or performing the pumping function of the heart. The Company'sproducts are used in the cardiac catheterization lab, or cath lab, by interventional cardiologists and in the heart surgery suite by heart surgeons for patients who are in need of hemodynamic support prophylactically or emergently before, during or after angioplasty or heart surgery procedures.

Key Statistics

Overview:

Market Capitalization, $K 11,953,354
Shares Outstanding, K 45,283
Annual Sales, $ 769,430 K
Annual Net Income, $ 259,020 K
Last Quarter Sales, $ 207,080 K
Last Quarter Net Income, $ 73,960 K
60-Month Beta 0.32
% of Insider Shareholders 3.40%
% of Institutional Shareholders 87.03%
Float, K 43,743
% Float 96.60%

Growth:

1-Year Return -38.58%
3-Year Return 123.76%
5-Year Return 927.92%
5-Year Revenue Growth 318.99%
5-Year Earnings Growth 1,141.38%
5-Year Dividend Growth 0.00%

Per-Share Information:

Most Recent Earnings 1.60 on 05/02/19
Next Earnings Date 08/01/19
Earnings Per Share ttm 3.63
EPS Growth vs. Prev Qtr 10.31%
EPS Growth vs. Prev Year 33.75%
Annual Dividend Rate, $ 0.00
Annual Dividend Yield 0.00%
Dividend Payout Ratio 0.00
Most Recent Split 2-1 on 10/02/00

ABMD Ratios

Ratio
Price/Earnings ttm 71.75
Price/Earnings forward 123.10
Price/Earnings to Growth 2.10
Return-on-Equity (After Tax) 20.32
Return-on-Assets (Before Tax) 18.10
Profit Margin % 33.66
Net Margin % -9.74
Debt/Equity 0.00
Price/Sales 15.33
Price/Cash Flow 65.16
Price/Book 12.65
Book Value/Share 20.78
Interest Coverage N/A
Want to use this as
your default charts setting?
Learn about our Custom Templates
Switch the Market flag
above for targeted data.
Open the menu and switch the
Market flag for targeted data.
Get Streaming Chart Updates
Switch your Site Preferences
to Interactive Chart
Read About Upcoming
Changes to This Feature
Need More Chart Options?
Right-click on the chart to open the Interactive Chart menu.

Free Barchart Webinar